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Abstract
Our study objective was to evaluate existing evidence on different types of support received by metastatic breast cancer patients
as well as the need for support expressed by such patients. We searched Medline and EMBASE up to January 2019 for survey
studies that aimed to assess any type of support amongwomen of any age, withmetastatic breast cancer diagnosis. Two reviewers
independently screened titles and abstracts, then full texts of retrieved records against inclusion/exclusion criteria, and extracted
the data and assessed the quality of included studies with AXIS tool. From a total of 2876 abstracts, we selected 100 potentially
eligible full-text articles, and finally, we included 12 records reporting on 11 studies. Due to the variability of methods used to
measure and define support, it was not possible to quantitatively synthesize data; therefore, we synthesized them narratively. The
quality of the included studies was moderate.We found that most patients are satisfied with the received psychosocial, emotional,
informational, and medical support. In the analysis of any support received from a certain type of group of people, we found that
the majority of patients reported receiving sufficient support from their family, friends, and healthcare providers. Ten studies
showed a high need for informational support. If asked about the need for psychosocial, medical, and sexual support, women also
declared the need for such support. Our review revealed that the patients generally receive support from their community but they
express high need for information and treatment choice. PROSPERO CRD42019127496
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Introduction
Breast cancer (BC) represents a significant public health bur-
den across the globe.Worldwide, 2.1 million newly diagnosed
female breast cancer cases were estimated to occur in 2018,
accounting for almost 1 in 4 cancer cases among women [1].
About 5–10% of patients in Western countries are initially
diagnosed with advanced (ABC) or metastatic breast cancer
(MBC) [2]. It is estimated that approximately 20–30% of early
BC patients may recur with MBC [3]. The precise number of
MBC patients is unknown, as most cancer registries record
primary diagnosis only [4, 5].
In 2016, the European School of Oncology established the
ABCGlobal Alliance. It is a platform developed to improve and
extend the lives of patients with ABC. In the Global Status of
Advanced/Metastatic Breast Cancer 2005–2015 Decade Report
[6], the authors stressed the need for holistic, individualized
communication about MBC. According to the report, patients
declare inadequate communication and understanding.
However, so far, no systematic review explored the evidence
on support among women withMBC. Therefore, the aim of this
systematic review is to evaluate existing evidence on different
types of support received by MBC patients as well as the need
for support expressed by them.
Methods
We prepared the protocol for our research before we com-
menced the study and we registered it on 20 June 2019 in
the International prospective register of systematic
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reviews—PROSPERO (CRD42019127496). In the reporting
of the results, we followed the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses guidelines.
Search Strategy
We searchedMedline and EMBASE on 18 January 2019 with
no language restrictions. Moreover, we searched on portals
and websites of professional organizations and reference lists
of identified reviews and we contacted experts in the field.We
included studies conducted from January 2008 as, after dis-
cussion with experts, during the last decade, the progress in
the treatment of breast cancer was so pronounced that it might
affect results. The search strategy included MESH/Emtree
terms and free text words related to metastatic breast cancer,
support, and surveys. The search strategy is presented in the
Supplementary material.
Studies’ Eligibility Criteria
The eligibility criteria for our review included the following:
(i) target population: women of any age, with metastatic breast
cancer diagnosis (TNM stage IV); studies involving patients
with different stages of breast cancer or different types of
cancer were included if > 50% of participants suffered from
advanced breast cancer; (ii) survey studies published from
2008 (last decade), without language restrictions, investigat-
ing any type of support received or expressed by participants
such as psychosocial, financial, medical, and informational
(studies assessing any of them) as defined by the authors of
the study; the frequency and intensity of support preferably
measured with validated scales; (iii) studies described in more
than one paper were all included but analyzed as one study.
We excluded conference abstracts and poster abstracts be-
cause they did not provide sufficient data on methods and
results.
Study Selection and Data Extraction
We downloaded search results to reference management soft-
ware (Mendeley) in order to remove duplicates. Two re-
viewers (JBC, MG) independently elected articles first on
the basis of titles and abstracts using Rayyan application [7]
and then based on full text against inclusion/exclusion criteria
and resolved disagreements through discussion. Before the
screening, reviewers underwent calibration process (of 50 ti-
tles and abstracts) twice to check the agreement rate. In both
attempts, we reached the pre-assumed 90% agreement rate.
Two reviewers extracted data independently and discussed
disagreements to reach consensus. Similarly, before extrac-
tion, we also carried out the calibration process on 3 papers
to rule out major disagreements and we calculated the
agreement rate between extractors to be 81%. When we could
not reach consensus, we involved a third author (MB).
Quality Assessment
Two independent reviewers (JBC, MG) assessed the quality
of each study using the Appraisal Tool for Cross-Sectional
Studies (AXIS) [8]. We chose this tool as it is specifically
designed for cross-sectional studies and only includes items
relevant to this design. It includes a total of 20 items (see
details in Supplementary material). Each study was awarded
“yes” if it satisfactorily met a criterion, while “no” was noted
if a study did not meet a criterion. As advised in the tool guide,
we also recorded “do not know” responses. We resolved dis-
agreements by a discussion between the two reviewers.
Data Synthesis
We extracted the relevant information from the included stud-
ies using a dedicated pre-piloted extraction form, which also
included quality assessment. After calibration exercises, we
collected the following data: country of the research, study
settings, timeframe, study objectives, funding, methodology,
and characteristics of the sample population.
The studies defined support in different ways.We extracted
the percentage of respondents indicating receiving a certain
type of support or expressing the need for such support. Due
to substantial variability in the populations including methods
used to measure support, different types of support, and dif-
ferent ways of presenting the data, we did not attempt a quan-
titative synthesis but decided to summarize the data narrative-
ly. Because it was not possible to summarize the data quanti-
tatively, we could not explore the potential for publication bias
with a funnel plot.
Results
Study Characteristic
Our initial searches resulted in 1017 Medline and 2006
EMBASE records. After removing duplicates, we screened
2876 records, which yielded 100 records for full-text assess-
ment. We included 11 studies published in 12 papers (Fig. 1,
Supplementary material) [9–20]. Two studies were described
in two papers [10, 16, 19, 20] while 1 paper included 2 studies
[11]. The list of excluded studies with reasons for exclusion is
presented in the Supplementary material. The characteristics
of included studies are presented in Table 1.
The included studies enrolled a total of 4614 participants
from 32 countries. The sample size varied between 52 and
1342 participants, with a median sample size of 419
participants.
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The questionnaires used by the researchers to measure sup-
port varied to a great extent.
Results of the quality assessment with AXIS are presented
in the Supplementary material. As the tool guide does not
specify how to summarize the results, in order to simplify
the assessment, we presented the total number of “yes”
awarded by each study in the study characteristics. The criteria
that were most commonly (in more than half of the studies)
not met or not reported included sample size justification,
sampling frame, sample selection, response rate, and non-
responders categorization. We analyzed both support already
received by women and support as an expressed need
(Table 2).
Support Received
The authors assessed any type of support received by patients,
as well as emotional, psychosocial, informational, and medi-
cal support. The highest number of studies (7) reported on any
type of support without any further specification of the type of
support but with a specified support provider. The majority of
patients received support from their family, friends, and
healthcare providers, but the minority of them reported satis-
faction with support from support groups and social services.
The detailed information concerning sources of support is
presented in Table 3.
Support as Expressed Need
The authors assess informational, medical, emotional, and
sexual needs for support. Ten out of 11 studies reported on
the need for informational support among MBC patients.
Most women required information regarding different issues
related to their diseases, such as treatment, disease, symptoms,
and side effects. The detailed information concerning topics of
interest of patients is presented in the Supplementary material.
The need for medical support was assessed in 2 studies. The
results are consistent: about one-third ofMBC patients want to
have access to more treatment choices.
Discussion
Our review revealed that the patients generally receive support
from their community but they express high need for informa-
tion and treatment choice.
This study is the first systematic review in this field, pro-
viding a critical summary of the current situation for
healthcare providers, policy-makers, and healthcare
managers.
In our literature search, we found no data from underdevel-
oped countries. That stays in accordance with the results of the
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Report [6]. They found commonality in many of the personal
challenges faced by patients with MBC, but the country in
which they were living was the most important factor
influencing the appropriate level of support. We also found
wide variability in the proportions of patients reporting receiv-
ing and needing support. It seems that European patients [11]
are less satisfied with the support received from family than
globally analyzed patients from North and South America,
Africa, and Europe [19]. The results of the assessment of
support from healthcare providers stay in accordance
irrespectively of origin. Support groups seem ineffective both
in Europe and Australia. It is hard to compare the levels of
psychosocial support as we only found two studies, one with
the smallest number of participants, coming from Romania,
and one from Australia. Two authors assessed the emotional
support, with the total number of participants being almost
2000 and the results are consistent. It seems that patients from
the USA have the highest informational needs [10, 12, 16, 19].
We suppose that is related to higher population awareness and
more patients’ involvement in decision-making in the USA
than in Europe.
Our research is not free from limitations. The ranges of the
tools and measures used in the analyzed research varied to a
large extent; therefore, it was not possible to quantitatively
synthesize the results of all studies in meta-analysis.
Moreover, several studies did not provide data necessary for
meta-analysis or data necessary to explore heterogeneity (such
as characteristics of the study population). Another concern is
a possible selection bias that could be attributed to the subject
of the questionnaire, i.e., patients dissatisfied with the support
they receive might be especially interested in expressing their
opinions.
The lack of validated tools limits the comparability of
the results and could even raise concerns about the validity
of certain studies. Only three studies reported on the vali-
dation of the survey [9, 12, 14] while one form was
pretested only [10].
Our quality assessment revealed the moderate quality of
the included studies. Most studies did not provide sample size
justification, sample selection, nor response rate and non-
responder categorization which might have introduced selec-
tion bias. Therefore, studies properly planned, using validated
tools, explaining sample selections are needed.
Despite our comprehensive search, we cannot exclude the
possibility that we missed studies which remained unpub-
lished. Additionally, we excluded studies published only as
conference or poster abstracts only, as they did not provide
sufficient data on methods and results.
Because quantitative analysis using meta-analysis was not
possible, we were unable to assess the publication bias with
the funnel plot. Hence, we cannot exclude possible publica-
tion bias.
The strength of this study to be underlined is the well-
recognized rigorous method of systematic review following
the protocol with defined methods registered in PROSPERO.
This systematic review contributes new valuable informa-
tion to the body of literature in the field of metastatic breast
cancer.
Conclusions
The findings of this review shed light on the needs of MBC
patients as well as on the fact that researchers pay little interest
in the exploration of the types and amount of support received
and expressed by MBC women. The global community must
work upon a strong foundation of knowledge on which to take
steps forward towards a multi-stakeholder drive for change.
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Table 3 Reported sources of any support, not further defined





Family 6 [11, 16–19] 57 [17]–98 [19]
Healthcare providers 4 [11, 14, 18] 73 [18]–85 [11] One study [14] used Visual Analogue Scale,
range 0–10, result 6.0
Friends 3 [11, 18] 59 [11]–87 [18] Reported 87% [18] concerned support received
from family and friends altogether
Support groups 2 33 [17]–36 [11]
Social services 1 7 [11]
Anyone 1 77 [18] Study reported 23% receiving no supportive care
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